文献速递垂体与肾上腺疾病

颅咽管瘤手术治疗与辅助治疗综述

Overview of surgical approaches and adjuvant therapy for treatment of craniopharyngiomas.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

颅咽管瘤是发生于鞍区及鞍上区的良性肿瘤,因毗邻视交叉、下丘脑和垂体,治疗极具挑战。手术切除为一线治疗,内镜下经鼻入路近年日益普及,可提供与开颅入路相似或略高的全切率及更高的视力保留率,但两种术式术后内分泌并发症风险仍显著。当前方案推荐最大安全切除后辅以放疗、囊内治疗或针对分子靶点的新型系统治疗。

要点

  • 手术切除是颅咽管瘤的一线治疗,内镜经鼻入路全切率与开颅相似或略高且视力保留更优。
  • 两种手术入路术后内分泌并发症风险均显著。
  • 推荐最大安全切除后辅以放疗,复发肿瘤常用放疗。

核心结论

  • 颅咽管瘤治疗需在最大安全切除与保护神经血管结构之间权衡,术后辅助治疗不可或缺。
  • 内镜经鼻入路在全切率和视力保留方面不劣于或优于开颅入路,但内分泌并发症风险仍高。
  • 分子机制进展为部分颅咽管瘤亚型提供了有前景的新型系统治疗。

研究设计与样本

  • 本文为综述,未报告系统检索范围或样本量。

主要发现

  • 颅咽管瘤见于成人和儿童,常表现为头痛、神经系统症状和垂体功能减退。
  • 内镜经鼻入路较开颅入路提供相似至略高的全切率及更高的视力保留或改善率。
  • 两种手术方式术后内分泌并发症风险均显著。
  • 囊内治疗包括近距离放疗、博来霉素和干扰素α治疗,成功率不一。

关键数值与推荐

  • 当前方案推荐最大安全切除后辅以辅助治疗。
  • 复发肿瘤常用放射治疗。

临床怎么用

  • 术前应评估肿瘤与视交叉、下丘脑和垂体的关系以制定个体化手术策略。
  • 术后需监测和管理内分泌并发症。
  • 对复发或无法全切的肿瘤可考虑放疗、囊内治疗或分子靶向系统治疗。

局限性

  • 本文为综述,未提供原始研究数据或系统评价方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Craniopharyngiomas are brain tumors that occur in the sellar and suprasellar regions and are seen in both adult and pediatric patients. They are benign tumors, but their location and relation with critical neurovascular structures, including optic chiasm, hypothalamus, and pituitary gland, make their treatment challenging. Patients often present with headaches, neurologic symptoms, and pituitary dysfunction. Surgical resection is the first line of treatment. Historically, surgeries for these tumors have involved open cranial approaches. However, endoscopic endonasal approaches have become increasingly more popular in recent years. They provide similar to slightly increased rates of gross total resection and increased rates of visual preservation or improvement. Unfortunately, both options still carry significant risk of postoperative endocrinopathies for these patients. Given the involvement of these tumors with surrounding structures, especially the hypothalamus, current protocols recommend maximal safe resection followed by adjuvant therapies. Radiation therapy for tumor recurrences is often used. Intracystic therapies, including brachytherapy, bleomycin, and interferon alpha therapy, have all been tried with varying success. Last, advances in the understanding of molecular underpinnings of these tumors have led to promising new systemic therapies for certain subset of these tumors.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Patel NP, Lu N, Hankinson TC, et al. Overview of surgical approaches and adjuvant therapy for treatment of craniopharyngiomas. J Clin Endocrinol Metab. 2026. PMID: 42333799. doi:10.1210/clinem/dgag242

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。